Research and development prospects of TRIM65
Authors:
Open Access
- 22 August 2025
- journal article
- review article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 151 (8) , 1-18
Abstract
Ubiquitination, the prevalent posttranslational modification, plays a crucial role in regulating protein function, localization, and degradation within cellular environments. As an E3 ubiquitin ligase, TRIM65 has been shown in various studies to facilitate the ubiquitination of specific substrates, thereby controlling inflammation, innate immune responses, cell proliferation, apoptosis, and tumor progression. Given the multifaceted and significant role of TRIM65, this review compiles existing research on TRIM65 and lays the groundwork for future studies aimed at uncovering the mechanisms of TRIM65. Further understanding of TRIM65’s interactions with its substrate proteins will offer valuable insights into the molecular underpinnings of certain diseases. Additionally, by identifying small molecules or inhibitors that target TRIM65, we may be able to develop novel drugs that modulate its activity. Such research could lead to more precise and effective treatments for conditions such as chronic inflammation, autoimmune diseases, and cancer. In summary, the study of TRIM65 not only enhances our understanding of fundamental cellular processes but also opens up new perspectives and avenues for the development of innovative therapies.Keywords
Funding Information
- Special Project for Clinical and Basic Sci &Tech Innovation of Guangdong Medical University (GDMULCJC2024122, GDMULCJC2024122, GDMULCJC2024122)
This publication has 155 references indexed in Scilit:
- TRIM65/NF2/YAP1 Signaling Coordinately Orchestrates Metabolic and Immune Advantages in Hepatocellular CarcinomaAdvanced Science, 2024
- Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0/G1 arrest and targeting MMP‐2/‐9 expression and activityBioFactors, 2022
- Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's PerspectiveAngewandte Chemie International Edition, 2020
- LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR‐1281/TRIM65 axisJournal of Cellular Physiology, 2019
- Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular CarcinomaHepatology, 2018
- Dual‐specificity phosphatase 6 deletion protects the colonic epithelium against inflammation and promotes both proliferation and tumorigenesisJournal of Cellular Physiology, 2018
- TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignanciesCell Biology International, 2018
- HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cellsHepatology, 2011
- Genome‐wide association studies of cerebral white matter lesion burdenAnnals of Neurology, 2011
- miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cellsInternational Journal of Cancer, 2008